The end-of-experiment blood and stool results show a real improvement pattern: iron availability recovered, WBC/CRP cooled, stool blood cleared on repeat, and metabolic markers stayed excellent. The remaining watch items are not the dramatic ones; they are the persistent-borderline ones: platelets/fibrinogen and IgA trend/formal SPEP interpretation.
Ferritin 43.28 → 61.60; TSAT 27.7% → 33.4%; hemoglobin 14.0 normal. The clean month looks like better iron availability, not active iron-deficiency anemia.
April FOB+/RBC+ changed to 2026-05-28 FOB negative and stool RBC absent. This cools the bleeding branch, but does not erase recurrence rules.
WBC normalized 13.1 → 7.7 and CRP stayed normal. Platelets improved 494 → 444, but remain above Biomed range; fibrinogen 3.9 is high-normal.
IgA fell 634.7 → 546.6 mg/dL. True protein electrophoresis shows no obvious narrow M-spike on the preserved graph; trend/formal interpretation now matters more than panic escalation.
Fasting glucose 5.39 mmol/L and insulin 6.7 µIU/mL give HOMA-IR about 1.61; this is not metabolic-syndrome physiology.
| Signal | What changed | Meaning |
|---|---|---|
| Best news | FOB negative and stool RBC absent on 2026-05-28 | The April stool-positive branch cools substantially when paired with improved iron markers and normal Hb. |
| Still watch | Platelets 444; fibrinogen 3.9; ESR 20 | This is not an emergency pattern, but the platelet/fibrinogen branch is not fully “normal.” |
| IgA branch | IgA lower but still high; SPEP has no obvious narrow spike | This shifts from missing-pattern-test anxiety toward trend/formal-read monitoring. |
| Cardiovascular context | Lp(a) remains the fixed high-risk anchor | Clean labs do not replace BP + echo/CAC/CCTA prevention work. |
| Experiment implication | The clean month produced a coherent improvement signal | Zero alcohol/smoking likely removed major noise; it does not prove one single cause. |
Ferritin rose from the non-fasting midpoint low of 43.28 to 61.60. TSAT rose to 33.4%. Hemoglobin remained normal. That combination argues against current iron-deficiency anemia and supports better iron availability during the clean month.
This is the key GI update. April FOB+/RBC+ was a real signal, but 2026-05-28 FOB negative + stool RBC absent cools the branch when viewed with improved ferritin/TSAT and normal hemoglobin. Future visible blood, iron decline, or repeat positivity would reopen it.
WBC went 13.1 → 8.2 → 7.7. CRP stayed normal at 2.52. This supports a reactive/exposure component, especially compared with the April WBC spike.
Platelets improved to 444, just below the common 450 threshold but still above Biomed range. Fibrinogen 3.9 g/L is shown as ×100 on this shared chart for scale. This is the main “keep watching” blood branch.
IgA fell from 634.7 to 546.6 mg/dL but remains high. The protein electrophoresis graph summary reports no obvious narrow M-spike, with mildly high beta fractions and normal gamma quantity. That shifts the branch toward trend + formal interpretation, not immediate panic escalation.
Fasting glucose and insulin give HOMA-IR ≈ 1.61. Triglycerides/HbA1c history already looked good. This matters because the inflammatory/CVD picture is not being driven by obvious metabolic syndrome.
| Branch | Status after these labs | Practical next move |
|---|---|---|
| GI bleeding / iron loss | Cooled: repeat stool negative, RBC absent, ferritin/TSAT better, Hb normal. | No default endoscopy from this result alone. Reopen by visible blood, repeat positivity, ferritin/TSAT/Hb drift, melena, or clinician concern. |
| Platelets / inflammatory-thrombotic context | Improved but not fully normal: platelets 444; fibrinogen 3.9; ESR 20. | Repeat CBC/fibrinogen by interval or clinician plan. Smear/molecular pathway only if persistence remains unexplained or worsens. |
| IgA | Lower but still high; SPEP-style result not obviously monoclonal. | Preserve graph/quantitation. Repeat quantitative immunoglobulins later; IFE/FLC only if formal read suspicious, IgA rises, or red flags appear. |
| CVD/Lp(a) | Still the big fixed risk domain; clean labs do not neutralize Lp(a) 838.6 mg/L. | BP profile, echo/valve baseline, CAC/CCTA route, ApoB/LDL target discussion remain high-yield. |
| Bloating/motility | Not answered by blood alone; stool consistency soft and stool blood clear are reassuring boundaries. | Analyze Tracker/Apple Health/stool-photo pattern separately. Do not use bloating as proof for or against bleeding. |
This report is a structured personal health-data interpretation, not a diagnosis or substitute for clinician review. The public link contains personal medical information because it was explicitly requested as a public shared-folder artifact. Source: refreshed medical overview cloud document, Health Knowledge Base topics, and Blood Test Explorer data updated on 2026-05-30.